arGEN-X advances a third therapeutic antibody program into preclinical development: http://t.co/hBB8aUOQ
posted 17 hours ago
FlandersBio has a structural partnership with a privileged number of strategic partners. These partners - Deloitte, Flanders Investment & Trade, Gimv & Biotech Fonds Vlaanderen, IWT, Janssen Pharmaceutica and VIB - help to realise FlandersBio’s course and mission. In this way FlandersBio aims to increase the involvement from the sector.
As a leading audit and consulting practice in Belgium, Deloitte offers value added services in audit, accounting, tax, consulting and corporate finance.
Flanders Investment & Trade provides confidential advice free of charge to businesses looking to set up or expand operations in the Flanders region of Belgium.
Gimv Life Sciences supports promising companies in the life sciences sector with venture capital. Gimv's long-term approach is particularly valuable in this capital-intensive sector characterised by long and...
The Biotech Fonds Vlaanderen was set up in 1994 to provide venture capital to existing and starting medium and large sized companies in the Flemish biotechnology sector.
The Institute for the promotion of Innovation by Science and Technology in Flanders (IWT) was established in 1991 by the Flemish government as a regional public institution to provide R&D and innovation support in...
Janssen Pharmaceutica is part of Johnson & Johnson. The research organization is called Janssen Research& Development, of which one third of the staff is based in Belgium and operates as a division of Janssen...
VIB is an entrepreneurial institute involved in frontline life sciences research and its translation in products and economic activities. VIB also offers bio-incubator and bio-accelerator facilities and aims to be a...
